7/2/2025InventisBio Launches First Phase III Trial of TYK2 Inhibitor D‑2570 i...

7/2/2025Betta's Tibremciclib Approved in China for Advanced HR+/HER2– Breast ...

7/2/2025NMPA Grants Marketing Approval to GeneScience's Firsekibart for Acute ...

7/2/2025China Grants Conditional Approval to Bebetter Medicine's Ifupinostat f...

7/2/2025Simcere's Suvemcitug Approved in China for Platinum-Resistant Ovarian ...

7/2/2025Biokin's Iza-bren Achieves Primary Endpoint in Phase III Trial for Nas...

7/1/2025Hengrui's Ivarmacitinib Approved in China for Severe Alopecia Areata

7/1/2025Hutchmed Receives Chinese Approval for Lung Cancer Drug Combo, Trigger...

6/30/2025QL Biopharma's Dual GLP‑1/FGF21 Agonist ZT‑003 Gains IND Nod in U.S....

6/30/2025Pfizer China's Emblaveo Cleared by NMPA for Tough Gram‑Negative Infec...

6/30/2025Cutia's Topical Finasteride Spray CU‑40102 Approved in China for Hair...

6/30/2025CTTQ's Anlotinib Wins Approval in China for First-Line Treatment of Ad...

6/28/2025I-Mab Unveils Encouraging Givastomig Results in First-Line Gastric Can...

6/27/2025Theravance Partner Viatris Lands NMPA Approval for YUPELRI, Unlocking ...

6/27/2025CARsgen Submits NDA for Satri‑cel, Poised to Be First CAR‑T for Soli...

6/24/2025IASO Bio Highlights CAR-T MS Study Results at EAN 2025

6/24/2025BrightGene Reports Strong Phase 2 Results for Dual Agonist BGM0504 and...

6/24/2025Aclaris Launches Phase 1a/1b Study of ATI-052

6/23/2025Sciwind's Ecnoglutide Achieves 15.4% Weight Loss in Chinese Obesity Ph...

6/20/2025MindRank's Oral GLP-1RA MDR-001 Achieves Promising Phase IIb Results i...

6/20/2025Simcere Gains Approval to Market Insomnia Drug Quviviq in China

6/20/2025Lepu Begins MRG007 Trial in China, Licenses Global Rights to ArriVent

6/20/2025CanSinoBIO Obtained NDA Approval for its 13-Valent Pneumococcal Polysa...

6/18/2025FDA Clears Boan Biotech to Advance Innovative CD228‑Targeting ADC BA1...

6/18/2025Abbisko Launches Pivotal Irpagratinib Trial Targeting FGFR4-Driven Liv...

6/17/2025Merck's Long-Acting RSV Antibody Clesrovimab Recommended for Priority ...

6/16/2025CARsgen Delivers Deep Responses with CT071 in Newly Diagnosed Multiple...

6/16/2025Hengrui Presents Positive Phase 2 Obesity Data at ADA 2025

6/14/2025Keymed Biosciences' BsAb Shows Promise in Autoimmune Hemolytic Anemia

6/13/2025Kelun Cleared for Clinical Trial of SKB315 and Tagitanlimab Combo in C...

Page:3/17 Total number of articles:504: [First][<<] [1] [2] [3] [4] [5] [>>] [End]